Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria
奥马佐单抗
安慰剂
医学
加药
胃肠病学
内科学
免疫球蛋白E
抗体
免疫学
病理
替代医学
作者
Allen P. Kaplan,Marta Ferrer,Jonathan A. Bernstein,Evgeniya Antonova,Benjamin Trzaskoma,Karina Raimundo,Karin Rosén,Theodore A. Omachi,Sam Khalil,James L. Zazzali
Benefits of omalizumab treatment were evident early (before week 4) in some patients and persisted to week 24. Use of 300 mg of omalizumab demonstrated best results in controlling CIU/CSU symptoms.
PDF的下载单位、IP信息已删除
(2025-6-4)
null
GingerF
互助
Sen
老李
寻道图强
欢呼凡雁
可耐的夜梅
优秀的友卉
wlffjessica
何土旦
CPD
无极微光
Criminology34
yyds
迪迦7777
科研狗
糟糕的铁锤
愔愔
LiW
皖公网安备34019202002308
